← SCP Cost Explorer Read on SCP Wiki ↗
SCP-5350 Keter ~ medium confidence
SCP-5350
Expected annual
$120.1B
One-time setup
$210.8B
Annual recurring
$105.7B
Personnel
8500
Foundation operational one-time setup ≈ $210.8B driven by vaccine manufacturing/distribution, Gen+ program setup, surveillance and Site-14 build; recurring Foundation operational costs ≈ $105.7B/yr (vaccine boosters/distribution, Gen+ operations, MTF operations, quarantine, R&D). Systemic economic impacts (meat-industry compensation, GDP/supply-chain losses) are tracked separately and estimated at hundreds of billions one-time and hundreds of billions per year; this report moves those items out of Foundation operational spend compared with the original stage-2 draft.
🏗️ One-Time Capital Costs Total: $210.8B
Initial Doses Inventory Cost $60.0B
[#3] Bulk production cost for initial campaign inventory (assumes ~4,000,000,000 doses × ~$15 per dose manufacturing including thaumaturgic augmentation processes). Itemized per-dose costing used instead of a single unsubstantiated round figure.
Distribution Dose Admin Cost $40.0B
[#4] Administration and frontline delivery cost for initial campaign (assumes ~4,000,000,000 administrations × ~$10 per administration for vaccinators, local logistics and safe handling).
Gene Synthesis Labs Capex $20.0B
[#19] Initial capital for centralized Gen+/Gen++ gene synthesis and high-containment vector production labs required if biological re-creation is pursued.
Contingency Reserve One Time $19.2B
[#28] One-time contingency (10% of the above one-time program components) to cover cost overruns, supply chain shocks, and escalation during initial rollout.
Surveillance Infrastructure $15.0B
[#7] Assay rollout, lab network expansion, field test kit production capacity and initial deployment to food-supply checkpoints and clinical centers.
Regional Breeding Facilities Setup $10.0B
[#19] Setup of multiple regional facilities for controlled breeding/recreation of edited species (containment, monitoring and release staging).
Controlled Culling And Recreation Logistics $10.0B
[#19] Field logistics, transport, and controlled removal/reintroduction assets for localized ecosystem interventions (initial tranche).
Ecosystem Field Trials And Monitoring Capex $10.0B
[#19] Large-scale field trials, environmental baseline studies and monitoring infrastructure to validate edited-species releases.
Manufacturing Plant Capex $8.0B
[#3] Capital to build/retrofit multiple sterile vaccine manufacturing lines worldwide to Foundation security/specification standards.
Cold Chain Infrastructure Capex $5.0B
[#4] Global cold-chain and secure transport upgrades (regional storage, localized cold units, temperature-monitored containers) sized for large-dose campaign.
Sanitation Program $5.0B
[#24] Capital retrofits and deep cleaning for priority food-processing facilities (pilot tranche targeted at highest-risk plants).
Qc And Thaum Facilities $2.0B
[#3] Quality-control, thaumaturgic infusion stations, and redundant assay/QC labs tied to manufacturing capacity.
International Ad Campaign $2.0B
[#6] Creative, initial international media buys and multi-language production for plant-based dietary campaign (initial multi-year spend).
Emergency Fleet $2.0B
[#25] Fleet acquisition/retrofit and refrigerated air/sea lift capacity for rapid distribution of vaccines, samples and MTF deployments.
Vaccinators Training Capex $500.0M
[#4,#17] One-time training and initial equipment for mass vaccinator corps (memetic safety procedures and thaumic-augmented injection protocols).
Biohazard Waste Equipment $500.0M
[#10] Capital equipment for centralized biohazard processing, air scrubbers for crematoria, and mobile waste-treatment assets.
Facilities $450.0M
[#1] Site-14 construction/outfitting (BSL-4 wet labs, thaumaturgic & memetic containment hardening, HVAC and waste-treatment tie-ins). Figure based on high-security lab benchmarks with added anomalous containment retrofits.
Memetic Delivery Systems $400.0M
[#5] Design and secure deployment channels for memetic anti-meat agent(s), including memetic-safety testing and hardened publishing/distribution pipelines.
Initial Research And Lab Setup $350.0M
[#2] R&D pilot programs, preclinical studies, memetic safety testing facilities, assay development and early-stage human-trial enablement (regulatory, ethics oversight capacity).
It Systems $300.0M
[#26] Dashboards, genomic surveillance compute, contact/memetic exposure tracking systems, and secure interagency data links.
Equipment $120.0M
[#1, #18] Laboratory hardware, imaging, containment cabinets, specialized cryo/thaumic shielding, and redundant monitoring equipment.
Mtf Ppe Outfitting $25.0M
[#16] One-time procurement of specialized thaumic-resistant PPE and field decontamination kits for MTF/health teams.
Secure Sample Storage $20.0M
[#18] Redundant vaults and secure cold-chain for SCP-5350 archival samples at Site-14.
🔄 Annual Recurring Costs Total: $105.7B/yr
Logistics And Transport $40.0B/yr
[#4, #25] Recurring distribution logistics for boosters, cold-chain operations, refrigerated transport and contracted air/sea lift.
Ecosystem Reconstruction Ops $40.0B/yr
[#19] Multi-year operational budget for Gen+/Gen++ ecological programs (breeding operations, field deployments, monitoring and staff). Large and uncertain; itemized in one-time and recurring components to avoid a single unsubstantiated round figure.
Contingency Reserve $9.6B/yr
[#28] Recurring contingency (≈10% of recurring program components) for surge manufacturing, mutation response and noncompliance escalations.
Subsidies For Plant Based $5.0B/yr
[#12] Foundation-funded market interventions and grants to accelerate plant-based food production in high-priority regions (smaller-scale targeted subsidies rather than funding an entire industry buyout).
Mtf Animal Culling Operations $3.0B/yr
[#8] Recurring MTF Beta-7 deployments, field teams, vehicles, euthanasia materials and sample collection for infected animals (targeted operations, not wholesale culling of all wildlife).
Quarantine Custodial Care $2.0B/yr
[#14] Long-term secure quarantine/care for clinically prioritized cases (Foundation realistically cannot house hundreds of millions; this funds ~10,000 secure beds plus medical/security staffing at fully burdened ~$200k/bed-year).
Staff Wages $1.7B/yr
[#1, #14, #17] Salaries and benefits (Site-14 scientific/medical staff, security/MTF personnel, quarantine staff, logistics/operations). Headcount and wage basis detailed in personnel section.
Cremation And Disposal $1.0B/yr
[#9] Cremation/incineration logistics for Foundation-handled infected animal remains (mobile incinerators, fuel and environmental mitigation for Foundation operations).
Research And Monitoring $800.0M/yr
[#2, #5, #7, #26] Ongoing R&D (vaccine & memetic safety), surveillance operations, assay processing and epidemiological modeling.
Environmental Monitoring $500.0M/yr
[#20] Long-term ecological studies and remediation monitoring following any targeted re-creation releases.
International Research Grants $500.0M/yr
[#27] Grants to partner institutions for coordinated trials, ecological studies and memetic-safety research.
Security Infrastructure $300.0M/yr
[#29] Protection for manufacturing, labs and high-value infrastructure against sabotage and intrusion.
Facilities Maintenance $200.0M/yr
[#1, #10] Ongoing Site-14 and specialized equipment maintenance, HVAC and life-safety servicing.
Psych Social Support $200.0M/yr
[#15] Survivor mental-health services, prosthetic/rehabilitation support programs and reintegration assistance for Foundation-managed cases.
Community Outreach $200.0M/yr
[#30] Local mitigation, culturally-tailored outreach, and liaison programs to reduce resistance to dietary and public-health measures.
Adverse Event Reserve $200.0M/yr
[#23] Annual reserve for compensation/legal costs arising from vaccine/memetic adverse events attributable to Foundation programs.
Training And Recruitment $150.0M/yr
[#17] Recruitment, hazard pay top-ups, specialized thaumaturgic/memetic training and exercises for MTFs and medical staff.
It Operations $150.0M/yr
[#26] Ongoing operation of epidemiology dashboards, genomic pipelines and memetic-exposure modeling compute.
Biohazard Waste Operations $100.0M/yr
[#10] Treatment of infectious waste streams from labs, quarantine and disposal operations.
Supplies And Consumables $50.0M/yr
[#16] PPE replacement, single-use disposables and routine lab consumables for research and field teams.
Mtf Ppe Consumables $25.0M/yr
[#16] Ongoing replacement of specialized PPE and decontamination chemicals.
Storage Security $5.0M/yr
[#18] Secure monitoring and maintenance budget for SCP-5350 sample custody.
Cover Story And Legal $0/yr
Set to $0 — concealment/cover-up is infeasible. SCP-5350 produced globally visible effects (billions infected and visible ocular growths, widespread mortality) and cannot be plausibly hidden; Foundation does not budget large-scale concealment. Resources are instead allocated to open coordination with partner organizations and lawful diplomatic channels (budgeted under other line items).
⚡ Cost Scenarios
📊 Baseline (baseline) $105.7B/yr
85.0% probability / year
Routine operational year: planned boosters, surveillance and Gen+ program proceed at steady rate; no major new global resurgence requiring emergency surge manufacturing or accelerated global ecosystem re-creation.
no major outbreak manufacturing and memetic countermeasures remain effective steady international cooperation
🚨 Major Outbreak Resurgence $183.7B/yr
12.0% probability / year +$78.0B vs baseline
Significant resurgence requiring emergency global vaccine surge, expanded culling/cremation operations, and emergency quarantine capacity scaling.
vaccine or memetic failure rapid zoonotic reservoir expansion or new aerosolization event political breakdowns blocking coordinated distribution
🚨 Genplus Ecosystem Reconstruction $275.7B/yr
3.0% probability / year +$170.0B vs baseline
Political decision or containment failure forces accelerated full-scale Gen+/Gen++ ecosystem reconstruction and species-edit release program, with very large capital deployments in a single year.
decision to accelerate biosphere re-creation containment failure with persistent global reservoirs needing ecological intervention
👥 Personnel 8500 total
Role Count Notes
Security Officer / MTF Agent 2500 [#1, #8, #29] Site and field security including MTF Beta-7 field operators and infrastructure protection.
Research Scientist 1200 [#2, #19, #26] Scientific staff for thaumaturgic/memetic R&D and ecological/genetic programs.
Research Technician / Lab Tech 1800 [#2, #7, #18] Laboratory technicians for BSL-4 operations, surveillance testing, and sample maintenance.
Engineer / Maintenance 600 [#1, #10, #25] Facility engineers, equipment maintenance, HVAC and waste-treatment operators.
Medical Officer 400 [#14, #15] Medical staff for quarantine care, clinical treatment and survivor services.
Administrative Staff 500 [#6, #13, #22] Program administration, logistics, partner liaison and program management.
Site Director / Executive Staff 20 [#1, #13] Executive oversight and international coordination.
MTF Rapid-Response / Logistics 300 [#25, #8] Rapid-deployment logistics crews and transport operators.
Psychologist / Social Worker 100 [#15] Psychological care and social reintegration staff for survivors.
IT / Bioinformatics Staff 150 [#26] IT, data analysis, modeling and genomic surveillance personnel.
Field Vaccinators & Logistics 700 [#4, #25] Vaccinators, cold-chain operators and field distribution personnel for campaigns and boosters.
Legal / Diplomatic Liaison 20 [#13, #21] Legal and diplomatic staff coordinating with partner organizations; cover-story concealment budgets are $0 because concealment is infeasible.
Community Outreach Workers 210 [#30] Local liaisons, cultural outreach and education teams for dietary-transition efforts.
📋 Confidence Notes
This re-evaluation used the complete article and original analyst notes to (a) move macroeconomic compensation/GDP losses into systemic_economic_impact (they are not Foundation spend by default), (b) zero out cover-story concealment budgets because concealment at the scale described is infeasible, and (c) itemize all >$1B Foundation line items (vaccine manufacturing, distribution, Gen+ program) as per reporting rules. Remaining material uncertainty: size/timing of Gen+ operations and international political cost-sharing; these drive medium-level confidence rather than high.
← SCP-5349 ↑ All SCPs SCP-5351 →